Business
View from the C-Suite: Aras Azadian, Chief Executive Officer, Avicanna Inc., tells his company's story. Filmed on July 18, 2019
View from the C-Suite: Aras Azadian, Chief Executive Officer, Avicanna Inc., tells his com...
About this update from Avicanna Inc
[{"type":"text","content":"\n\n\n\nView from the C-Suite: Aras Azadian, Chief Executive Officer, Avicanna Inc., tells his company's story. Filmed on July 18, 2019\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, Aug. 6, 2019\n\n\n\nTORONTO, Aug. 6, 2019 /CNW/ - \n\n \n  \n\n \nhttps://www.youtube.com/watch?v=7nFM0_fhCpk \nThe View from the C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.  Videos provide insight into how company executives think in the current business environment.  To see the latest View from the C-Suite videos visit www.tmxmoney.com/en/news/csuite.html) \nAbout Avicanna Inc. (TSX: AVCN)\nAvicanna is an Ontario corporation focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products through its two main business segments, cultivation and research and development.\nAvicanna's two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna's cultivation activities. These two companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including cannabidiol (CBD) and tetrahydrocannabinol (THC).\nAvicanna's research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna's scientific team develops products, and Avicanna has also engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto for the purpose of optimizing and improving upon its products.\nAvicanna's research and development and cultivation activities are focused on the development of its key products, including plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics and Extracts (defined as plant-derived cannabinoid extracts and purified cannabinoids, including distillates and isolates), with a goal of...